Related references
Note: Only part of the references are listed.Therapeutic Antisense Targeting of Huntingtin
Anne Smith et al.
DNA AND CELL BIOLOGY (2020)
AAV5-miHTT Gene Therapy Demonstrates Sustained Huntingtin Lowering and Functional Improvement in Huntington Disease Mouse Models
Elisabeth A. Spronck et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Targeting Huntingtin Expression in Patients with Huntington's Disease
Sarah J. Tabrizi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
A divalent siRNA chemical scaffold for potent and sustained modulation of gene expression throughout the central nervous system
Julia F. Alterman et al.
NATURE BIOTECHNOLOGY (2019)
AAV5-miHTT Lowers Huntingtin mRNA and Protein without Off-Target Effects in Patient-Derived Neuronal Cultures and Astrocytes
Sonay Keskin et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
AAV5-miHTT Gene Therapy Demonstrates Broad Distribution and Strong Human Mutant Huntingtin Lowering in a Huntington's Disease Minipig Model
Melvin M. Evers et al.
MOLECULAR THERAPY (2018)
Therapeutic efficacy of regulable GDNF expression for Huntington's and Parkinson's disease by a high-induction, background-free GeneSwitch vector
Shi Cheng et al.
EXPERIMENTAL NEUROLOGY (2018)
AAV5-miHTT gene therapy demonstrates suppression of mutant huntingtin aggregation and neuronal dysfunction in a rat model of Huntington's disease
J. Miniarikova et al.
GENE THERAPY (2017)
Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotides
Naoki Iwamoto et al.
NATURE BIOTECHNOLOGY (2017)
Dicer-independent processing of small RNA duplexes: mechanistic insights and applications
Elena Herrera-Carrillo et al.
NUCLEIC ACIDS RESEARCH (2017)
Elimination of huntingtin in the adult mouse leads to progressive behavioral deficits, bilateral thalamic calcification, and altered brain iron homeostasis
Paula Dietrich et al.
PLOS GENETICS (2017)
A novel neurodevelopmental disorder associated with compound heterozygous variants in the huntingtin gene
Lance H. Rodan et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2016)
Identification of novel genetic causes of Rett syndrome-like phenotypes
Fatima Lopes et al.
JOURNAL OF MEDICAL GENETICS (2016)
Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study
Richard S. Finkel et al.
LANCET (2016)
Ablation of huntingtin in adult neurons is nondeleterious but its depletion in young mice causes acute pancreatitis
Guohao Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Design, Characterization, and Lead Selection of Therapeutic miRNAs Targeting Huntingtin for Development of Gene Therapy for Huntington's Disease
Jana Miniarikova et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2016)
Onset Time and Durability of Huntingtin Suppression in Rhesus Putamen After Direct Infusion of Antihuntingtin siRNA
Richard Grondin et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2015)
Huntington disease: natural history, biomarkers and prospects for therapeutics
Christopher A. Ross et al.
NATURE REVIEWS NEUROLOGY (2014)
A fully humanized transgenic mouse model of Huntington disease
Amber L. Southwell et al.
HUMAN MOLECULAR GENETICS (2013)
Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease
Kirupa Sathasivam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Six-month partial suppression of Huntingtin is well tolerated in the adult rhesus striatum
Richard Grondin et al.
BRAIN (2012)
Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin Synthesis
Holly B. Kordasiewicz et al.
NEURON (2012)
Huntington's disease: from molecular pathogenesis to clinical treatment
Christopher A. Ross et al.
LANCET NEUROLOGY (2011)
Preclinical Safety of RNAi-Mediated HTT Suppression in the Rhesus Macaque as a Potential Therapy for Huntington's Disease
Jodi L. McBride et al.
MOLECULAR THERAPY (2011)
Eight Years of Clinical Improvement in MPTP-Lesioned Primates After Gene Therapy With AAV2-hAADC
Piotr Hadaczek et al.
MOLECULAR THERAPY (2010)
Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice
I Dragatsis et al.
NATURE GENETICS (2000)
Wild-type Huntingtin protects from apoptosis upstream of caspase-3
D Rigamonti et al.
JOURNAL OF NEUROSCIENCE (2000)
Share Paper
